David Nielsen Appointed Chief Revenue Officer at Novaprime
May 15, 2025 - 09:50
David Nielsen has officially taken on the role of chief revenue officer at Novaprime, a company specializing in mortgage technology solutions. With an extensive background in the mortgage industry, Nielsen brings two decades of sales expertise to his new position. His previous experience includes a significant tenure at Dark Matter Technologies, previously known as Black Knight, where he held the position of senior vice president of national sales.
At Novaprime, Nielsen will be instrumental in driving revenue growth and expanding the company’s market presence. The firm is known for its innovative offerings in real-time mortgage intelligence and secondary marketing automation, making it a key player in the evolving landscape of mortgage technology. Nielsen’s appointment is expected to bolster Novaprime’s strategic initiatives and enhance its competitive edge in the industry. His proven track record in sales leadership is anticipated to contribute significantly to the company's future success.
MORE NEWS
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...